Oracle Investment Management

Latest statistics and disclosures from ORACLE INVESTMENT MANAGEMENT's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are AXK, NXTM, Tesaro, Mazor Robotics Ltd. equities, QDEL. These five stock positions account for 65.68% of ORACLE INVESTMENT MANAGEMENT's total stock portfolio.
  • Added to shares of these 3 stocks: Tesaro, Intrexon, AXK.
  • Reduced shares in these 8 stocks: Mazor Robotics Ltd. equities, MBLX, PACB, QDEL, NXTM, ARAY, AMRN, shares Agenus.
  • Sold out of its positions in MBLX.
  • As of June 30, 2016, ORACLE INVESTMENT MANAGEMENT has $429.58M in assets under management (AUM). Assets under management grew from a total value of $384.58M to $429.58M.
  • Independent of market fluctuations, ORACLE INVESTMENT MANAGEMENT was a net seller by $2.57M worth of stocks in the most recent quarter.

ORACLE INVESTMENT MANAGEMENT portfolio companies for June 2016 quarter

Company (Ticker) Portfolio Weight Share Count Price Last Trade
Accelr8 Technology Corporation (AXK) 17.04 5.09M 14.39 0.00
NxStage Medical (NXTM) 13.48 2.67M 21.68 16.68
Tesaro 13.05 666956 +4.00% 84.05 0.00
Mazor Robotics Ltd. equities 11.58 2.77M -4.00% 17.98 0.00
Quidel Corporation (QDEL) 10.53 2.53M 17.86 25.06
Opko Health (OPK) 8.51 3.91M 9.34 14.08
Pacific Biosciences of California (PACB) 5.21 3.18M -3.00% 7.03 5.81
Accuray Incorporated (ARAY) 3.00 2.48M -2.00% 5.19 8.54
Biolase Technology (BLTI) 2.87 10.53M 1.17 0.00
Amarin Corporation (AMRN) 2.86 5.69M -2.00% 2.16 1.94
Hansen Medical (HNSN) 2.73 4.49M 2.61 0.79
Intrexon 2.63 459529 +13.00% 24.61 0.00
Vermillion (VRML) 2.23 8.62M 1.11 1.76
shares Agenus 1.75 1.86M 4.05 0.00
Transition Therapeutics 1.31 3.82M 1.47 0.00
Contrafect 0.80 1.18M 2.89 0.00
Biogen Idec (BIIB) 0.38 6723 241.71 415.20
Second Sight Med Prods 0.04 50804 3.58 0.00
ZIOPHARM Oncology (ZIOP) 0.01 6661 5.55 13.14